Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffi Bekeredjian

Showing results (11-20 of 257) with videos related to

Pageof 26
Sort By:
Herz|September 16, 2022
[Management of chronic coronary syndrome]Udo Sechtem, Andreas Seitz, Peter Ong, et al.
European Heart Journal. Case Reports|August 12, 2024
ST-segment elevation myocardial infarction without culprit lesion-a case report picturing the challenging interplay of epicardial atherosclerosis and coronary artery spasmKristina Wachter, Elif Akyol, Raffi Bekeredjian, et al.
BMJ Case Reports|July 29, 2024
Concurrent existence of cold agglutinin disease and ANCA-associated vasculitis with fulminant pulmonary-renal syndrome poses significant treatment challengesMoritz Schanz, Benedikt Wagner, Raffi Bekeredjian, et al.
Current Pharmaceutical Design|February 23, 2012
Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectivesNicolas A Geis, Hugo A Katus, Raffi Bekeredjian
Cardiovascular Research|November 14, 2006
Targeting the heart with gene therapy-optimized gene delivery methodsOliver J Müller, Hugo A Katus, Raffi Bekeredjian
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2010
New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterizationSteliyan Tinkov, Gerhard Winter, Conrad Coester, et al.
ESC Heart Failure|January 23, 2020
Late diagnosis of Barth syndrome in a 39-year-old patient with non-compaction cardiomyopathy and neutropeniaAndreas Seitz, Annely Hinck, Raffi Bekeredjian, et al.
Coronary Artery Disease|July 9, 2026
Management of multivessel disease in patients with ST-segment elevation myocardial infarction: questioning routine immediate complete revascularization in all patientsTim Heller, Peter Ong, Udo Sechtem, et al.
Journal of the American College of Cardiology|February 1, 2005
Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicineRaffi Bekeredjian, Paul A Grayburn, Ralph V Shohet
Journal of Pharmaceutical Sciences|November 4, 2008
Microbubbles as ultrasound triggered drug carriersSteliyan Tinkov, Raffi Bekeredjian, Gerhard Winter, et al.
Pageof 26

Showing results (11-20 of 257) with videos related to

Sort By:
Pageof 26
Herz|September 16, 2022
[Management of chronic coronary syndrome]Udo Sechtem, Andreas Seitz, Peter Ong, et al.
European Heart Journal. Case Reports|August 12, 2024
ST-segment elevation myocardial infarction without culprit lesion-a case report picturing the challenging interplay of epicardial atherosclerosis and coronary artery spasmKristina Wachter, Elif Akyol, Raffi Bekeredjian, et al.
BMJ Case Reports|July 29, 2024
Concurrent existence of cold agglutinin disease and ANCA-associated vasculitis with fulminant pulmonary-renal syndrome poses significant treatment challengesMoritz Schanz, Benedikt Wagner, Raffi Bekeredjian, et al.
Current Pharmaceutical Design|February 23, 2012
Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectivesNicolas A Geis, Hugo A Katus, Raffi Bekeredjian
Cardiovascular Research|November 14, 2006
Targeting the heart with gene therapy-optimized gene delivery methodsOliver J Müller, Hugo A Katus, Raffi Bekeredjian
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2010
New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterizationSteliyan Tinkov, Gerhard Winter, Conrad Coester, et al.
ESC Heart Failure|January 23, 2020
Late diagnosis of Barth syndrome in a 39-year-old patient with non-compaction cardiomyopathy and neutropeniaAndreas Seitz, Annely Hinck, Raffi Bekeredjian, et al.
Coronary Artery Disease|July 9, 2026
Management of multivessel disease in patients with ST-segment elevation myocardial infarction: questioning routine immediate complete revascularization in all patientsTim Heller, Peter Ong, Udo Sechtem, et al.
Journal of the American College of Cardiology|February 1, 2005
Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicineRaffi Bekeredjian, Paul A Grayburn, Ralph V Shohet
Journal of Pharmaceutical Sciences|November 4, 2008
Microbubbles as ultrasound triggered drug carriersSteliyan Tinkov, Raffi Bekeredjian, Gerhard Winter, et al.
Pageof 26